Ian Wilding Selected Research

Delayed-Action Preparations

1/2007

Systemic availability of the active metabolite hydroxy-fasudil after administration of fasudil to different sites of the human gastrointestinal tract.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ian Wilding Research Topics

Disease

1	Seizures (Absence Seizure) 09/2010
1	Insulin Resistance 12/2009
1	Dyslipidemias (Dyslipidemia) 12/2009
1	Type 2 Diabetes Mellitus (MODY) 11/2008
1	Stable Angina 01/2007
1	Human Influenza (Influenza) 05/2003

Drug/Important Bio-Agent (IBA)

1	Levetiracetam (Keppra)FDA LinkGeneric 09/2010
1	acipimoxIBA 12/2009
1	Glucose (Dextrose)FDA LinkGeneric 12/2009
1	Niacin (Nicotinic Acid)FDA LinkGeneric 12/2009
1	Exenatide (Byetta)FDA Link 11/2008
1	fasudil (AT 877)IBA 01/2007
1	rho-Associated KinasesIBA 01/2007
1	Delayed-Action PreparationsIBA 01/2007
1	Oseltamivir (Tamiflu)FDA Link 05/2003
1	ProdrugsIBA 05/2003